Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The history of the research of iron in parkinsonian substantia nigra.

Literature DB >> 22941506

The history of the research of iron in parkinsonian substantia nigra.

Andrzej Friedman¹, Jolanta Galazka-Friedman.

Abstract

The role of iron in pathogenesis of Parkinson's disease is widely discussed in the literature. The authors present the history of studies of iron in parkinsonian tissue from the substantia nigra.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Iron

Year: 2012 PMID： 22941506 PMCID： PMC3505548 DOI： 10.1007/s00702-012-0894-8

Source DB: PubMed Journal: J Neural Transm (Vienna) ISSN： 0300-9564 Impact factor: 3.575

18 in total

1. The effect of age on the non-haemin iron in the human brain.

Authors: B HALLGREN; P SOURANDER
Journal: J Neurochem Date: 1958-10 Impact factor: 5.372

Review 2. The ferritins: molecular properties, iron storage function and cellular regulation.

Authors: P M Harrison; P Arosio
Journal: Biochim Biophys Acta Date: 1996-07-31

3. Iron in parkinsonian and control substantia nigra--a Mössbauer spectroscopy study.

Authors: J Gałazka-Friedman; E R Bauminger; A Friedman; M Barcikowska; D Hechel; I Nowik
Journal: Mov Disord Date: 1996-01 Impact factor: 10.338

4. Studies on Parkinson's disease including x-ray fluorescent spectroscopy of formalin fixed brain tissue.

Authors: K M Earle
Journal: J Neuropathol Exp Neurol Date: 1968-01 Impact factor: 3.685

5. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.

Authors: P Riederer; E Sofic; W D Rausch; B Schmidt; G P Reynolds; K Jellinger; M B Youdim
Journal: J Neurochem Date: 1989-02 Impact factor: 5.372

6. Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.

Authors: D A Loeffler; J R Connor; P L Juneau; B S Snyder; L Kanaley; A J DeMaggio; H Nguyen; C M Brickman; P A LeWitt
Journal: J Neurochem Date: 1995-08 Impact factor: 5.372

7. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains.

Authors: J R Connor; B S Snyder; P Arosio; D A Loeffler; P LeWitt
Journal: J Neurochem Date: 1995-08 Impact factor: 5.372

8. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.

Authors: Baptiste A Faucheux; Marie-Elise Martin; Carole Beaumont; Jean-Jacques Hauw; Yves Agid; Etienne C Hirsch
Journal: J Neurochem Date: 2003-09 Impact factor: 5.372

9. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.

Authors: D T Dexter; F R Wells; A J Lees; F Agid; Y Agid; P Jenner; C D Marsden
Journal: J Neurochem Date: 1989-06 Impact factor: 5.372

10. Regional metal concentrations in Parkinson's disease, other chronic neurological diseases, and control brains.

Authors: R J Uitti; A H Rajput; B Rozdilsky; M Bickis; T Wollin; W K Yuen
Journal: Can J Neurol Sci Date: 1989-08 Impact factor: 2.104

12 in total

1. Neurophysiological studies and non-motor symptoms prior to ataxia in a patient with machado-joseph disease: trying to understand the natural history of brain degeneration.

Authors: José Luiz Pedroso; Edson Bor-Seng-Shu; Pedro Braga-Neto; Rodrigo Souza Ribeiro; Márcio Luiz Escorcio Bezerra; Lucila B F do Prado; Ilza Rosa Batista; Helena Alessi; Manoel Jacobsen Teixeira; Gilberto Mastrocola Manzano; Gilmar Fernandes do Prado; Orlando Graziani Povoas Barsottini
Journal: Cerebellum Date: 2014-08 Impact factor: 3.847

Review 2. Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors: Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal: Mol Neurobiol Date: 2015-10-14 Impact factor: 5.590

Review 3. New Insights into the Role of Ferritin in Iron Homeostasis and Neurodegenerative Diseases.

Authors: Na Zhang; Xiaoqi Yu; Junxia Xie; Huamin Xu
Journal: Mol Neurobiol Date: 2021-01-28 Impact factor: 5.590

4. Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.

Authors: Wu Xu; Yan Zhi; Yongsheng Yuan; Bingfeng Zhang; Yuting Shen; Hui Zhang; Kezhong Zhang; Yun Xu
Journal: J Neural Transm (Vienna) Date: 2018-05-10 Impact factor: 3.575

5. Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease.

Authors: Guillaume Grolez; Caroline Moreau; Bernard Sablonnière; Guillaume Garçon; Jean-Christophe Devedjian; Sayah Meguig; Patrick Gelé; Christine Delmaire; Regis Bordet; Luc Defebvre; Ioav Z Cabantchik; David Devos
Journal: BMC Neurol Date: 2015-05-06 Impact factor: 2.474

6. Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients.

Authors: Belén Fernández; Isidro Ferrer; Fernando Gil; Sabine Hilfiker
Journal: Toxicol Rep Date: 2017-03-31

7. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.

Authors: Etheresia Pretorius; Martin J Page; Sthembile Mbotwe; Douglas B Kell
Journal: PLoS One Date: 2018-03-01 Impact factor: 3.240

8. Mapping Chemical Elements and Iron Oxidation States in the Substantia Nigra of 6-Hydroxydopamine Lesioned Rats Using Correlative Immunohistochemistry With Proton and Synchrotron Micro-Analysis.

Authors: Asuncion Carmona; Stéphane Roudeau; Laura Perrin; Carole Carcenac; Delphine Vantelon; Marc Savasta; Richard Ortega
Journal: Front Neurosci Date: 2019-09-26 Impact factor: 4.677

9. Diet-Induced Obesity Disrupts Trace Element Homeostasis and Gene Expression in the Olfactory Bulb.

Authors: Melissa S Totten; Derek M Pierce; Keith M Erikson
Journal: Nutrients Date: 2020-12-21 Impact factor: 5.717

10. Iron and inflammation: in vivo and post-mortem studies in Parkinson's disease.

Authors: Antonio Martin-Bastida; Bension Shlomo Tilley; Sukhi Bansal; Steve M Gentleman; David T Dexter; Roberta J Ward
Journal: J Neural Transm (Vienna) Date: 2020-10-20 Impact factor: 3.575